C.F.R. homeSearch C.F.R.
C.F.R.Title 21Chapter I—Food and Drug Administration, Department of Health and Human ServicesSubchapter H—Medical DevicesPart 801—LabelingSubpart A—General Labeling Provisions

21 C.F.R. § 801.1 (2026)

Medical devices; name and place of business of manufacturer, packer or distributor

Edition and currency
eCFR text as of Sept. 29, 2026. The text is the edition Syfert holds; for a past event, check the version in force on that date.
Other sources
CURRENTeCFR text as of Sept. 29, 2026 cited 1988–2024 30citing cases
At a glance

Courts have cited this section in 30 opinions since 1988, 2 of them in the last five years. The most litigated part is subsection (d) (3 cases).

(a) The label of a device in package form shall specify conspicuously the name and place of business of the manufacturer, packer, or distributor.

(b) The requirement for declaration of the name of the manufacturer, packer, or distributor shall be deemed to be satisfied, in the case of a corporation, only by the actual corporate name which may be preceded or followed by the name of the particular division of the corporation. Abbreviations for “Company,” “Incorporated,” etc., may be used and “The” may be omitted. In the case of an individual, partnership, or association, the name under which the business is conducted shall be used.

(c) Where a device is not manufactured by the person whose name appears on the label, the name shall be qualified by a phrase that reveals the connection such person has with such device; such as, “Manufactured for ___”, “Distributed by _____”, or any other wording that expresses the facts.

(d) The statement of the place of business shall include the street address, city, State, and Zip Code; however, the street address may be omitted if it is shown in a current city directory or telephone directory. The requirement for inclusion of the ZIP Code shall apply only to consumer commodity labels developed or revised after the effective date of this section. In the case of nonconsumer packages, the ZIP Code shall appear on either the label or the labeling (including the invoice).

(e) If a person manufactures, packs, or distributes a device at a place other than his principal place of business, the label may state the principal place of business in lieu of the actual place where such device was manufactured or packed or is to be distributed, unless such statement would be misleading.

The 20 cases that cite 21 C.F.R. § 801.1 most heavily, weighted by court and treatment. RelevanceNewestTreatment
1
GREENJoyce A. Moore v. Kimberly-Clark Corp., 867 F.2d 243 (5th Cir. 1989).
cites § 801.1 4×cited by 57 cases
Where it cites § 801.1
“§ 360k and 21 C.F.R. § 801.1 (b) preempt all state law claims asserted against the manufacturer of the *244 tampons.”
The case’s holding
Federal medical device regulations preempt state tort claims regarding inadequate warnings but do not preempt claims based on defective design, composition, or construction.
Later courts cite it for
“there are no federal regulations on tampon design, composition, or construction,” · 2 citing courts
2
GREENCaplinger v. Medtronic, Inc., 784 F.3d 1335 (10th Cir. 2015).
cites § 801.1 2×cited by 56 cases
Where it cites § 801.1
“at 498 -99 (quoting 21 C.F.R. § 801.1 (d)). Put differently, a device must undergo the premarket approval process — or, the Court suggested, perhaps something like it.”
The case’s holding
The Medical Device Amendments preempt state law tort claims that impose new safety or effectiveness requirements on a federally approved device, regardless of whether the claim involves off-label use.
Later courts cite it for
“a district court may grant judgment as a matter of law under federal rule of civil procedure 12(b)(6) on the basis of an affirmative defense like preemption when the law compels that result.” · 6 citing courts
3
GREENIn re Medtronic, Inc., Implantable Defibrillators, 465 F. Supp. 2d 886 (D. Minn. 2006).
cites § 801.1 2×cited by 21 cases
Where it cites § 801.1
“” 21 C.F.R. § 801.1 (d). Because Minnesota, along with most other states, has adopted the UCC implied warranty provision, plaintiffs’ implied warranty claim is not preempted.”
Later courts cite it for
“to the extent plaintiffs' breach of express warranty claim is predicated on medtronic's failure to adhere to fda labeling or packaging requirements, the claim is not preempted,” · 2 citing courts
4
GREENEllen Mendes v. Medtronic, Inc., 18 F.3d 13 (1st Cir. 1994).
cites § 801.1 1×cited by 224 cases
Where it cites § 801.1
“21 C.F.R. §§ 801.1 , 801.15, 801.109. These regulations, which were in effect when plaintiffs particular pacemaker was implanted, exempt such devices from the requirement that there be directions to a layperson on how to use the product safely, if the package describes, inter…”
The case’s holding
The Medical Device Amendments expressly preempt state law claims that impose requirements different from or in addition to federal regulations regarding device labeling and manufacturing.
Later courts cite it for
“the non-moving party bears the burden of placing at least one material fact into dispute.” · 26 citing courts
5
GREENBravman v. Baxter Healthcare Corp., 842 F. Supp. 747 (S.D.N.Y. 1994).
cites § 801.1 2×subsections: (d) 2×cited by 32 cases
Where it cites § 801.1
“1 (d), whether the absence of specific federal counterpart regulations prescribing the design and labeling of heart valves preempts state tort claims, or alternately, whether the fact that a device has received Class III premarket approval classification under the MDA…”
The case’s holding
Federal regulations that merely identify a device category do not constitute specific requirements that preempt state common law duty to warn claims.
Later courts cite it for
“an 'identification provision' in the federal regulations does not act as a specific requirement which would preempt state common law.” · 2 citing courts
6
GREENSlater v. Optical Radiation Corp., 756 F. Supp. 370 (N.D. Ill. 1991).
cites § 801.1 3×cited by 12 cases
Where it cites § 801.1
“6 This is made clear in 21 C.F.R. § 801.1 (d) which provides that: State or local requirements are preempted only when the Food and Drug Administration has established specific counterpart regulations or there are other specific requirements applicable to a particular device…”
7
GREENBerger v. Pers. Prods., Inc., 797 P.2d 1148 (Wash. 1990).
cites § 801.1 2×cited by 15 cases
Where it cites § 801.1
“11 While affirming the District Court's holding that plaintiff's state tort law warnings and instructions claims were preempted, the United States Court of Appeals for the Fifth Circuit reversed the District Court's finding that plaintiff's state tort law design defect claims…”
Later courts cite it for
“flederal law preempts state law when congress intends to occupy a given field, when state law directly conflicts with federal law, or when state law would hinder accomplishment of the full purposes and objectives of the federal law.” · 2 citing courts
8
GREENSpychala v. G.D. Searle & Co., 705 F. Supp. 1024 (D.N.J. 1988).
cites § 801.1 1×cited by 33 cases
Where it cites § 801.1
“21 C.F.R. § 801.1 . Searle argues that, although the Cu-7 had originally been categorized by the FDA as a “new drug,” the Medical Device Amendments included transitional provisions pursuant to which certain devices formerly treated as drugs would be reclassified as “Class III”…”
The case’s holding
A prescription drug manufacturer discharges its duty to warn by adequately informing the prescribing physician as learned intermediary, and FDA-approved patient labeling satisfies any direct warning duty.
Later courts cite it for
“the physician is in the best position to take into account the propensities of the drug and the susceptibilities of the patient, and to give a highly individualized warning to the ultimate user based on the physician's specialized knowledge.” · 3 citing courts
9
GREENZhou v. Desktop Metal, Inc., 120 F. 4th 278 (1st Cir. 2024).
cites § 801.1 1×cited by 6 cases
Where it cites § 801.1
“" 21 C.F.R. § 801.1 (a). It is unlawful to introduce or deliver for introduction into interstate commerce a device that is "misbranded," see 21 U.”
10
GREENRosci v. AcroMed, Inc., 669 A.2d 959 (Pa. Super. Ct. 1995).
cites § 801.1 1×cited by 26 cases
Where it cites § 801.1
“, 21 C.F.R. §§ 801.1 , 801.4, 801.5, 801.6, 801.”
The case’s holding
The learned intermediary doctrine does not bar claims for breach of express warranty, and federal medical device regulations do not preempt express warranty claims.
Later courts cite it for
“the intended 'user' in a case involving a prescription drug or device is, of course, the prescribing physician.” · 2 citing courts
11
YELLOWSam Feldt v. Mentor Corp., 61 F.3d 431 (5th Cir. 1995).
cites § 801.1 1×cited by 23 cases
Vacated: 2 citing opinions add another limit ("vacated (caution)").
Where it cites § 801.1
“See 21 C.F.R. § 801.1 et seq.; id. § 895.25; see also id.”
Later courts cite it for
“preemption does not depend on the route the product takes to the market, but on whether there are any specific federal requirements applicable to the device.” · 2 citing courts
12
GREENBokis v. Am. Med. Sys., Inc., 875 F. Supp. 748 (W.D. Okla. 1995).
cites § 801.1 2×cited by 7 cases
Where it cites § 801.1
“, citing 21 C.F.R. §§ 801.1 , 801.15, 801.109. Although the state law standard concerning labeling requirements resembled the federal requirements, the court found the two standards may differ as applied, and a label in compliance with FDA requirements may be found by the…”
Later courts cite it for
“would be contrary to the determinations necessarily made by the fda” · 2 citing courts
13
GREENRinehart v. Int'l Playtex, Inc., 688 F. Supp. 475 (S.D. Ind. 1988).
cites § 801.1 1×cited by 22 cases
Where it cites § 801.1
“As the Court sees it, the issue here is whether a jury imposing a tampon labeling or warning standard different from the federal standard constitutes the establishment of a state requirement within the meaning of 21 U.”
14
GREENPoloney v. Tambrands, Inc., 399 S.E.2d 208 (Ga. 1991).
cites § 801.1 1×cited by 21 cases
Where it cites § 801.1
“Pursuant to 21 CFR § 801.1 (d), state requirements are preempted “only when the Food and Drug Administration has established specific counterpart regulations or there are other specific requirements applicable to a particular device under the act.”
Later courts cite it for
“the supremacy clause of the united states constitution dictates that federal law preempts inconsistent state law.” · 2 citing courts
15
GREENHunsaker v. Surgidev Corp., 818 F. Supp. 744 (M.D. Pa. 1992).
cites § 801.1 1×cited by 18 cases
Where it cites § 801.1
“1 (d), when read in conjunction with 21 C.F.R. § 801.1 (b), and 21 U.S.C. § 360k(a), provides for federal preemption of state law (or cause of action) due to the convergence of FDCA, MDA, and IDE.”
Later courts cite it for
“fundamental difference between a device approved by the fda for manufacture arid sale - that is, approved under the relevant regulations of the fdca and mda - and a device approved sufficiently safe and effective for investigation - that is, exempted from the fdca and mda under the ide,” · 1 citing court
16
GREENOja v. Howmedica, Inc., 848 F. Supp. 905 (D. Colo. 1994).
cites § 801.1 1×cited by 16 cases
Where it cites § 801.1
“21 C.F.R. §§ 801.1 , 801.15, and 801.109.”
17
GREENMeyer v. Int'l Playtex, Inc., 724 F. Supp. 288 (D.N.J. 1988).
cites § 801.1 1×cited by 14 cases
Where it cites § 801.1
“The FDA has specifically stated what must appear on tampon boxes and inserts in order to comply with federal law and reserved the power to approve or disapprove the language. Under state law, the jury could presumably evaluate defendant's labeling on a reasonableness standard…”
18
GREENBrown v. Medtronic, Inc., 852 F. Supp. 717 (S.D. Ind. 1994).
cites § 801.1 1×subsections: (d)cited by 12 cases
Where it cites § 801.1
“§] 360k and 21 C.F.R. 801.1(d).” Bravman, 842 F.Supp.”
Later courts cite it for
“the general regulations for class ii devices do not rise to the level to cause preemption under the mda.” · 2 citing courts
19
GREENBurgstahler v. AcroMed Corp., 670 A.2d 658 (Pa. Super. Ct. 1995).
cites § 801.1 1×cited by 9 cases
Where it cites § 801.1
“, 21 C.F.R. §§ 801.1 , 801.4, 801.5, 801.6, 801.”
20
GREENBejarano ex rel. Bejarano v. Int'l Playtex, Inc., 750 F. Supp. 443 (D. Idaho 1990).
cites § 801.1 1×cited by 8 cases
Where it cites § 801.1
“21 C.F.R. § 801.1 (d). The only state law claims that are preempted by § 360k(a) are those dealing with inadequate warnings or labeling.”

Show all 30 citing cases (list view) →

The flag is Syfertize’s treatment of the citing case itself, not of the statute. “Where it cites” is the passage in the opinion; the holding is a summary of the whole case and may concern another point. Annotations are extracted automatically from the opinions in the Syfert caselaw corpus.

Citing cases by year
198820062024

One bar per year. Tallest: 8 cases in 1995. These are opinions in the Syfert collection, which holds more of some courts’ recent opinions than their older ones, so a rise can reflect what the collection holds and not more litigation.

By court
S.D. Ind.3S.D.N.Y.31st Cir.23rd Cir.25th Cir.2D.N.J.2Pa. Super. Ct.210th Cir.1

The 8 courts with the most citing cases, of 21 courts in all.

By subsection
(d)3 cases
Bravman v. Baxter Healthcare Corp., 842 F. Supp. 747 (S.D.N.Y. 1994).“1 (d), whether the absence of specific federal counterpart regulations prescribing the design and labeling of heart valves preempts state tort claims, or alternately, whether the fact that a device has received Class III premarket approval classification under the MDA…”
Brown v. Medtronic, Inc., 852 F. Supp. 717 (S.D. Ind. 1994).“§] 360k and 21 C.F.R. 801.1(d).” Bravman, 842 F.Supp.”
Richman v. W.L. Gore & Assocs., Inc., 881 F. Supp. 895 (S.D.N.Y. 1995).

Show all 30 citing cases (list view) →

Enactment and amendments

Syfert holds no separate history line for this section. Where this code prints a source or history note, it appears with the text, usually at the end.

Versions

Edition shown: eCFR text as of Sept. 29, 2026. Syfert holds no earlier or later version of this section.

C.F.R. Home  |  Search C.F.R.  |  Search cases for this section  |  syfert.com